Pfizer
PFE
PFE
3,151 hedge funds and large institutions have $201B invested in Pfizer in 2022 Q2 according to their latest regulatory filings, with 130 funds opening new positions, 1,401 increasing their positions, 1,260 reducing their positions, and 122 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more capital invested
Capital invested by funds: $196B → $201B (+$5.06B)
1% more call options, than puts
Call options by funds: $2.9B | Put options by funds: $2.89B
1% less funds holding
Funds holding: 3,189 → 3,151 (-38)
Holders
3,151
Holding in Top 10
251
Calls
$2.9B
Puts
$2.89B
Top Buyers
| 1 | +$1.54B | |
| 2 | +$1.38B | |
| 3 | +$1.28B | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$556M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$478M |
Top Sellers
| 1 | -$355M | |
| 2 | -$311M | |
| 3 | -$295M | |
| 4 |
Barclays
London,
United Kingdom
|
-$210M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$193M |